Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms
NCT05637671
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
146
Enrollment
OTHER
Sponsor class
Conditions
Vasomotor Symptoms
Interventions
DRUG:
oxybutynin ER
DRUG:
Paroxetine CR
Sponsor
Cairo University